CLINICAL_TRIALS
trial_result
· 2011-12-09
Clinical Trial Update: Trial of FK614 in Type 2 Diabetics Inadequately Controlled on a Sulfonylurea [Phase 2]
Summary
A completed Phase 2 trial evaluating FK614 in adults with Type 2 diabetes inadequately controlled on a sulfonylurea.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Astellas Pharma Inc | Conditions: Diabetes Mellitus | Phase 2 | Status: COMPLETED